Publication
Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results
dc.contributor.author | Busch, Catharina | |
dc.contributor.author | Fraser-Bell, Samantha | |
dc.contributor.author | Iglicki, Matias | |
dc.contributor.author | Lupidi, Marco | |
dc.contributor.author | Couturier, Aude | |
dc.contributor.author | Chaikitmongkol, Voraporn | |
dc.contributor.author | Giancipoli, Ermete | |
dc.contributor.author | Rodríguez-Valdés, Patricio J. | |
dc.contributor.author | Gabrielle, Pierre-Henri | |
dc.contributor.author | Laíns, Inês | |
dc.contributor.author | Santos, Ana Rita | |
dc.contributor.author | Cebeci, Zafer | |
dc.contributor.author | Amphornphruet, Atchara | |
dc.contributor.author | Degenhardt, Valentin | |
dc.contributor.author | Unterlauft, Jan-Darius | |
dc.contributor.author | Cagini, Carlo | |
dc.contributor.author | Mané-Tauty, Valérie | |
dc.contributor.author | Ricci, D'Amico Giuseppe | |
dc.contributor.author | Hindi, Isaac | |
dc.contributor.author | Agrawal, Kushal | |
dc.contributor.author | Chhablani, Jay | |
dc.contributor.author | Loewenstein, Anat | |
dc.contributor.author | Zur, Dinah | |
dc.contributor.author | Regak, Matus | |
dc.date.accessioned | 2021-02-09T10:17:20Z | |
dc.date.available | 2021-02-09T10:17:20Z | |
dc.date.issued | 2019-09-21 | |
dc.description.abstract | The beneficial effect of an early switch to DEX implant in DME non-responders seen at month 12 was main- tained during the second year. A later switch from anti-VEGF to steroids still provided significant improvement. Eyes continued on anti-VEGF over a period of 24 months maintained vision. A quarter of eyes, which had not improved vision at 12 months, exhibited a delayed response to treatment. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Busch, C., Fraser-Bell, S., Iglicki, M. et al. Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results. Acta Diabetol 56, 1341–1350 (2019). https://doi.org/10.1007/s00592-019-01416-4 | pt_PT |
dc.identifier.doi | 10.1007/s00592-019-01416-4 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.22/16930 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Springer | pt_PT |
dc.relation.publisherversion | https://link.springer.com/article/10.1007%2Fs00592-019-01416-4 | pt_PT |
dc.subject | Refractory diabetic macular edema | pt_PT |
dc.subject | Anti-VEGF therapy | pt_PT |
dc.subject | Dexamethasone implant | pt_PT |
dc.subject | Intravitreal therapy | pt_PT |
dc.subject | Long- term outcome | pt_PT |
dc.title | Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
person.familyName | Santos | |
person.givenName | Ana Rita | |
person.identifier.ciencia-id | 0911-4138-0C3A | |
person.identifier.orcid | 0000-0003-0139-0285 | |
rcaap.rights | closedAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | d71931b8-d869-4334-993c-ba14ad713f01 | |
relation.isAuthorOfPublication.latestForDiscovery | d71931b8-d869-4334-993c-ba14ad713f01 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- ART_Ana_Rita_Santos_5.pdf
- Size:
- 931.61 KB
- Format:
- Adobe Portable Document Format